CDH3
Cadherin-3
Also known as: CADH3_HUMAN, CDHP, PCAD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P22223
- Gene
- CDH3
- Ensembl
- ENSG00000062038
- Chromosome
- 16
- Canonical length
- 829 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cell Junctions
OverviewNCBI Gene
This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. This gene is located in a gene cluster in a region on the long arm of chromosome 16 that is involved in loss of heterozygosity events in breast and prostate cancer. In addition, aberrant expression of this protein is observed in cervical adenocarcinomas. Mutations in this gene are associated with hypotrichosis with juvenile macular dystrophy and ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome (EEMS). [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
829 residues, UniProt reviewed canonical sequence.
>P22223|CDH3
1 MGLPRGPLAS LLLLQVCWLQ CAASEPCRAV FREAEVTLEA GGAEQEPGQA LGKVFMGCPG
61 QEPALFSTDN DDFTVRNGET VQERRSLKER NPLKIFPSKR ILRRHKRDWV VAPISVPENG
121 KGPFPQRLNQ LKSNKDRDTK IFYSITGPGA DSPPEGVFAV EKETGWLLLN KPLDREEIAK
181 YELFGHAVSE NGASVEDPMN ISIIVTDQND HKPKFTQDTF RGSVLEGVLP GTSVMQVTAT
241 DEDDAIYTYN GVVAYSIHSQ EPKDPHDLMF TIHRSTGTIS VISSGLDREK VPEYTLTIQA
301 TDMDGDGSTT TAVAVVEILD ANDNAPMFDP QKYEAHVPEN AVGHEVQRLT VTDLDAPNSP
361 AWRATYLIMG GDDGDHFTIT THPESNQGIL TTRKGLDFEA KNQHTLYVEV TNEAPFVLKL
421 PTSTATIVVH VEDVNEAPVF VPPSKVVEVQ EGIPTGEPVC VYTAEDPDKE NQKISYRILR
481 DPAGWLAMDP DSGQVTAVGT LDREDEQFVR NNIYEVMVLA MDNGSPPTTG TGTLLLTLID
541 VNDHGPVPEP RQITICNQSP VRQVLNITDK DLSPHTSPFQ AQLTDDSDIY WTAEVNEEGD
601 TVVLSLKKFL KQDTYDVHLS LSDHGNKEQL TVIRATVCDC HGHVETCPGP WKGGFILPVL
661 GAVLALLFLL LVLLLLVRKK RKIKEPLLLP EDDTRDNVFY YGEEGGGEED QDYDITQLHR
721 GLEARPEVVL RNDVAPTIIP TPMYRPRPAN PDEIGNFIIE NLKAANTDPT APPYDTLLVF
781 DYEGSGSDAA SLSSLTSSAS DQDQDYDYLN EWGSRFKKLA DMYGGGEDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDH3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 52 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 52 nTPM
- ovary: 32 nTPM
- esophagus: 25 nTPM
- skin: 24 nTPM
- thymus: 18 nTPM
- fallopian tube: 16 nTPM
Single-cell type
- respiratory basal cells: 361 nCPM
- granulosa cells: 350 nCPM
- salivary myoepithelial cells: 320 nCPM
- basal keratinocytes: 298 nCPM
- salivary basal cells: 275 nCPM
- retinal pigment epithelial cells: 264 nCPM
Immune cell
- basophil: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 101 nTPM
- hippocampal formation: 8.2 nTPM
- cerebellum: 4.9 nTPM
- spinal cord: 4.9 nTPM
- cerebral cortex: 4.3 nTPM
- basal ganglia: 4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CDH3.
Disease | AllUniProt
Conditions CDH3 is implicated in, by any mechanism.
- Hypotrichosis congenital with juvenile macular dystrophy (HJMD) MIM:601553
- Ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome (EEMS) MIM:225280
Disease | GeneticClinVar
56 pathogenic / likely-pathogenic of 838 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital hypotrichosis with juvenile macular dystrophy
- Retinal dystrophy
- EEM syndrome
- Hypotrichosis with juvenile macular dystrophy
- Retinal disorder
Disease | ImmuneIEDB
Conditions an epitope on CDH3 was assayed in.
- skin melanoma T cell
- intrahepatic gall duct cancer T cell
- bile duct cancer T cell
- gallbladder cancer T cell
- pancreatic cancer T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.08
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adherens junction organization
- calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
- cell adhesion
- cell migration
- cell morphogenesis
- cell-cell adhesion mediated by cadherin
- cell-cell junction assembly
- hair cycle process
- hair follicle maturation
- homophilic cell adhesion via plasma membrane adhesion molecules
- keratinization
- negative regulation of transforming growth factor beta receptor signaling pathway
- positive regulation of canonical Wnt signaling pathway
- positive regulation of insulin-like growth factor receptor signaling pathway
- positive regulation of keratinocyte proliferation
- positive regulation of melanin biosynthetic process
- regulation of transport
- retina homeostasis
- visual perception
- negative regulation of timing of catagen
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDH3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDH3 as an antibody target. Whether an autoantibody or antibody against CDH3 could matter depends on whether native CDH3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDH3 is annotated at the cell surface, where native CDH3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CDH3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...